Recombinant TBEV gE middle Protein (aa 50-250) (VAng-Cr6558)
Datasheet
Specifications
Source
E. coli
Target
Tick-borne Encephalitis Virus
Type
Other Viral Antigens
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
20mM MES, pH 6.5 containing 8M urea, 200mM Sodium Chloride, 0.05% Tween-20.
Purity
> 95% pure by SDS-PAGE.
Storage
Store at -18°C to 4°C.
Antigen Information
Introduction
Tick-borne encephalitis virus is the virus associated with tick-borne encephalitis. TBEV is endemic in an area ranging from northern China and Japan, through far-eastern Russia to Europe, and is maintained in cycles involving Ixodid ticks (Ixodes ricinus and Ixodes persulcatus) and wild vertebrate hosts. The virus causes a potentially fatal neurological infection, with thousands of cases reported annually throughout Europe. It was initially isolated in 1937. Three virus sub-types are described: European or Western tick-borne encephalitis virus, Siberian tick-borne encephalitis virus, and Far eastern Tick-borne encephalitis virus (formerly known as Russian Spring Summer encephalitis virus, RSSEV). TBE has a significant mortality rate depending upon the strain of virus or may cause long-term neurological/neuropsychiatric sequelae in people affected. In this review, we comprehensively reviewed TBEV, its epidemiology and pathogenesis, the clinical manifestations of TBE, along with vaccination and prevention.
Alternative Names
TBEV
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
